InvestorsHub Logo

AAstra

07/20/16 1:17 PM

#4107 RE: James salmon #4106

Great points James -- thanks for keeping things in perspective. As many have always said, Opdivo and Keytruda are to market but it is the combo results that will really blow people's minds.

shub

07/20/16 3:15 PM

#4113 RE: James salmon #4106

There are a number of checkpoint inhibitors out there.
I think CGEN has identified a dozen or so ....But can't get anybody to invest in them.
My guess is that a tumor specific, genetically determined, cluster of checkpoint inhibitors, combined with our constructs would show dramatic results.
Successfully fighting cancer is a multiple modality proposition.
Presently, we tend to try this, and when it doesn't produce a complete cure, we dawdle around and then try that, allowing the tumor to mutate it's way around each medicine. I see that as a mistake.
Instead,we should be attacking the tumor in multiple ways at once, to the extent the patient can tolerate it.